CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED – Trademark Portfolio
Entity Type: 03
CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RKDRKD. The owner is based in HONG KONG.
ROOM 1508, 15/F.,OFFICE TOWER TWO,GRAND PLAZA,625 NATHAN ROAD MONG KOK
HONG KONG 999077 , HK
Showing of trademarks Trademarks
Trademark Classifications
CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED have?
CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED file in?
CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED's most well-known trademarks?
CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED's registered trademark portfolio includes well-known marks such as RKDRKD. These are among 1 currently registered trademark in the portfolio.
What is CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED's trademark registration success rate?
CADE WANLI HEALTH TECHNOLOGY INDUSTRYGROUP CO., LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.